Kwanhyeong Jo

Prof. Kwanhyeong Jo


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
CWChangsoo Woo
Changsoo Woo
KJKwanhyeong Jo
Kwanhyeong Jo
BSBeomseok Sohn
Beomseok Sohn
KPKisung Park
Kisung Park
HCHojin Cho
Hojin Cho
SLSeung-Koo Lee
Seung-Koo Lee
Woo C, et al. Korean J Radiol. 2023 Jan;24(1):51-61. https://doi.org/10.3348/kjr.2022.0397

4 November 2021 in Cancers
Verified
Journal Article
Open access
PDF file
HCHojin Cho
Hojin Cho
SKSoyoung Kim
Soyoung Kim
KJKwanhyeong Jo
Kwanhyeong Jo
YJYong Hyu Jeong
Yong Hyu Jeong
WKWon Jun Kang
Won Jun Kang
Background: We aimed to evaluate the prognostic role of metabolic parameters on baseline F-18 fluorodeoxyglucose (FDG) PET/CT in patients with human papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma (OPSCC). Methods: We retrospectively reviewed patients who were diagnosed with nonmetastatic HPV-related OPSCC using the 8th TNM staging system from 2010 to 2015 and underwent baseline F-18 FDG PET/CT. Tumor SUVmax to liver SUVmean ratio (SUVmax-TLR), metabolic tumor volume (MTV), tumor total lesion glycolysis to liver SUVmean ratio (TLG-TLR), and coefficient of variation (CV) of the primary tumor were measured. Patients were primarily treated with surgery or radiotherapy. Endpoints were progression-free survival (PFS) and overall survival (OS). Results: Ninety consecutive patients (male, 72; female, 18) were enrolled. They were followed up for a median of 77.4 months (interquartile range, 48.4–106.4). Sixteen patients progressed, and 13 died. Multivariate analysis revealed that patients with advanced age, overall stage, and higher SUVmax-TLR or CV had poorer PFS and OS. Conclusion: Higher SUVmax-TLR and CV of the primary tumor on baseline F-18 FDG PET/CT were associated with poorer PFS and OS in patients with nonmetastatic HPV-related OPSCC. Further study is warranted to address the possible implications of F-18 FDG PET/CT on treatment de-intensification in these patients.

1 January 2023 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
KJKwanhyeong Jo
Kwanhyeong Jo
JKJinna Kim
Jinna Kim
HCHojin Cho
Hojin Cho
WKWon Jun Kang
Won Jun Kang
SLSeung-Koo Lee
Seung-Koo Lee
BSBeomseok Sohn
Beomseok Sohn
Jo KH, et al. Yonsei Med J. 2023 Dec;64(12):738-744. https://doi.org/10.3349/ymj.2023.0187

5 February 2026 in Research Square
Verified
Preprint
Open access
PDF file
KJKwanhyeong Jo
Kwanhyeong Jo
BKBaek-Hui Kim
Baek-Hui Kim
JKJeongWoo Kim
JeongWoo Kim
SCSeongJi Choi
SeongJi Choi
HKHyoJung Kim
HyoJung Kim
SKSungeun Kim
Sungeun Kim
Objective: To evaluate the relationship between laboratory markers and pancreatic 18 F-fluorodeoxyglucose (FDG) uptake on staging 18 F-FDG positron emission tomography/computed tomography (PET/CT) in patients with pancreatic or periampullary malignancies, and to clarify the interpretative implications of laboratory findings when assessing pancreatic FDG uptake. Materials and Methods: This retrospective study included 95 patients with histologically confirmed pancreatic or periampullary malignancies who underwent staging FDG PET/CT and had available laboratory data. C-reactive protein, amylase, and lipase levels were measured, and pancreatic FDG uptake was assessed using the maximum standardized uptake value and the pancreas-to-blood pool ratio (P/B ratio). The associations between laboratory markers and FDG uptake parameters were evaluated using Spearman’s and partial Spearman’s correlation analyses. Group-based comparisons were performed using the Kruskal–Wallis test with post-hoc analysis. Results: The P/B ratio differed significantly among the groups (p = 0.010), with the highest values observed in those with concurrent elevations in C-reactive protein and pancreatic enzyme levels. After adjusting for other laboratory markers, serum lipase levels remained independently associated with both the maximum standardized uptake value and P/B ratio, and C-reactive protein levels remained independently associated with P/B ratio. Representative cases showed malignant pancreatic involvement with inflammation-like FDG uptake and normal laboratory marker levels. Conclusion: Pancreatic FDG uptake was significantly influenced by inflammatory laboratory markers, particularly when assessed using the P/B ratio. Elevated serum lipase levels warrant caution when interpreting increased pancreatic FDG uptake as malignant, whereas normal laboratory markers should not be considered reassuring of benign inflammatory uptake. Integrating laboratory findings with the P/B ratio may improve the interpretation of pancreatic PET/CT findings during staging of pancreatic malignancies.